Homepage Inria website

Section: Software and Platforms

Vidjil – Quantifying lymphocytes rearrangements in high-throughput sequencing data

Actively developed

Software self-assessment: A-3-up4, SO-3, SM-2-up3, EM-3, SDL-4, DA-4, CD-4, MS-4, TPM-4

Software web site : http://bioinfo.lifl.fr/vidjil

Vidjil implements a two-stage strategy for fast clustering and quantification of clones coming from immunological rearrangements in genomic sequences. It is currently used in “minimal residual disease” following, but could have other uses in immunology research. Vidjil is currently under test at the Lille hospital, and is planned to be tested in another hematological lab. In 2013, the development of Vidjil was supported by the regional project ABILES: an engineer (Marc Duez) developed for 5 months a graphical interface for using Vidjil. We plan to release a first production version to the hospital during 2014.